Pediatric COVID-19 patient with exacerbated generalized pustular psoriasis

Pala, Erdal; Melikoğlu, Mehmet; Erkayman, Merve Hatun

doi:10.1590/0037-8682-0318-2021

Cited by 5 publications

(2 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…1 Multiple reports proposing COVID-19 infection as a precipitating factor for GPP development have emerged (Table 1). [5][6][7][8] It is proposed that the inflammatory response to the viral infection-specifically, the surge in tumour necrosis factorα (TNFα), interleukin(IL)-1 alpha and beta, and IL-17-may cause initiation or recurrence of the eruption in this context. 6 There have also been several cases of GPP following COVID-19 mRNA vaccination (Table 1) which is consistent with a recurrent GPP flare in our patient after he received his Pfizer vaccination.…”

Section: Con Clus I On S and Per S Pec Tive Smentioning

confidence: 99%

Generalized pustular psoriasis‐like widespread eruption following COVID‐19 infection in a patient with spondyloarthropathy on adalimumab

Kamal

Riew

Hijaz

et al. 2023

Experimental Dermatology

View full text Add to dashboard Cite

Generalized pustular psoriasis (GPP) is a form of pustular psoriasis that is distinguished by recurring or persistent outbreaks of non‐acral primary sterile pustules. These eruptions can occur with or without systemic inflammation. Various factors, such as medications, stress and viral infection, have been identified as potential triggers for GPP flares. While several cases have detailed GPP‐like eruptions in the setting of coronavirus disease 2019 (COVID‐19) infection, few have explored the interplay between infection and biologic use in the development of GPP. In this case, we detail the history and management of a 45‐year‐old male patient with a prior history of spondyloarthropathy managed on a tumour necrosis factor‐α inhibitor and recent COVID‐19 infection presenting with a new, spreading pustular rash.

show abstract

Section: Con Clus I On S and Per S Pec Tive Smentioning

confidence: 99%

Generalized pustular psoriasis‐like widespread eruption following COVID‐19 infection in a patient with spondyloarthropathy on adalimumab

Kamal

Riew

Hijaz

et al. 2023

Experimental Dermatology

View full text Add to dashboard Cite

show abstract

“…During the Sars-CoV-2 pandemic, several case reports of worsening of psoriasis due to Sars-CoV-2 disease (COVID-19) or Sars-CoV-2 vaccinations have been reported. [1][2][3][4] The aim of our report is to evaluate the patients perception on the impact of Sars-CoV-2 pandemic on their cutaneous condition. We administered two surveys to psoriatic patients in the period between March 2021 and June 2021 to evaluate the impact of lockdown and Sars-CoV-2 on their cutaneous condition or treatments and to understand the perception on Sars-CoV-2 vaccination and if it could interfere with psoriasis and its treatments.…”

mentioning

confidence: 99%